CAR T-cell trial offers promising second-line therapy for B-cell lymphoma

October 17, 2018 Providence News Team

Patients who have relapsed or failed first-line treatment for aggressive forms of B-cell non-Hodgkin lymphoma may qualify to receive a promising CAR T-cell therapy in a new clinical trial at Providence Cancer Institute:

Study: Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-NHL-006) for B-cell non-Hodgkin lymphoma

JCAR017 is an investigational CAR T-cell therapy that modifies a patient’s own T-cells to express proteins called CARs (chimeric antigen receptors), which help T-cells recognize tumor cells and go after them. A Phase I study of JCAR017 in people with aggressive forms of B-cell lymphoma found that it provided “a durable reduction or eradication of cancer,” including complete cancer eradication in just over half of the patients. Read more in Lymphoma News Today.

CAR T-cell therapy is a major research priority for the Earle A. Chiles Research Institute, a division of Providence Cancer Institute in the Robert W. Franz Cancer Center. Read more about JCAR017 in Immuno-Oncology News, and find out more about adoptive T-cell therapy research at Providence.

Providence is one of only two centers in the United States currently participating in this clinical trial. For more information or to enroll a patient, call our Clinical Research office at 503-215-2614. Call us early for consideration, before the patient receives a salvage therapy or stem cell transplant.

See more studies
New research studies are added frequently. Please visit our website to see all studies in all cancer types currently open at Providence Cancer Institute.

Enter content here

About the Author

The Providence News Team brings you the updates to keep you informed about what's happening across the organizational ecosystem. From partnerships to new doctor announcements, we are committed to keeping you informed.
More Content by Providence News Team

Welcome to your journey for creating a healthier you

CAR T-cell trial offers promising second-line therapy for B-cell lymphoma

About the Author

Previous Article

Next Article

CAR T-cell trial offers promising second-line therapy for B-cell lymphoma

About the Author

Previous Article

Next Article

Most Recent Articles

Back pain is among the most common and debilitating conditions, capable of hindering our mobility, disrupting our daily activities and diminishing our quality of life.

The hospital was among 16 organizations celebrated for transforming healthcare delivery across Partnership Health Plan’s 24-county service region.

ncy medical care in the community.” Queen of the Valley Medical Center’s level III trauma center and emergency department will remain open 24/7/365 throughout the renovations.

https://www.youtube.com/watch?v=BtIJsq7J--w

Providence Alaska Children’s Hospital formally dedicated the Panda Cares Center of Hope during a celebration event on Friday, June 20.

Providence Saint Joseph Medical Center in Burbank, Calif., has earned its second Magnet® recognition, a prestigious honor bestowed by the American Nurses Credentialing Center.

Providence Alaska Chief Executive Ella Goss, MSN, RN, has announced her retirement as chief executive of Providence Alaska, the state’s largest health care provider, beginning Aug. 1.

Now is the time to stand up for those who rely on Medicaid as a lifeline and safety net.

Providence Queen of the Valley Medical Center is honored to have received the CalAIM Make a Difference Award from Partnership HealthPlan of California for advancing innovative and holistic health care

When Janet was diagnosed with breast cancer, she knew she wouldn't be able to afford treatment. But thanks to Medicaid, she was able to get the life-saving treatment she needed.

In 2024, Providence contributed $188 million to programs, charity care, unpaid costs of Medicare and Medi-Cal across Northern California according to the Annual Report to Our Communities, published on

A generous gift of plush blankets helps comfort patients during their chemotherapy treatments at Providence Cancer Institute Newberg Clinic.

Magnet® designation is considered gold standard for nursing excellence

St. Mary security officers on patrol carrying Narcan for opioid overdoses

Providence Santa Rosa Memorial Hospital is pleased to announce the appointment of Kendra Crawford, MS, BSN, RN, CPHQ, NEA-BC, FACHE, as the new chief nursing officer.

Hospital caregivers enjoyed a fun surprise last week when cast members from the Max Original medical drama “The Pitt” stopped by for a visit.

In partnership with the American Heart Association, the training kiosk will travel to multiple LA locations to teach lifesaving skills.

Prioritize your skin health with these expert tips.